MDGL

MADRIGAL PHARMACEUTICALS INC

MDGL·558868105·US·Common Stock·Healthcare - Biotechnology-Activist

MDGL (MADRIGAL PHARMACEUTICALS INC) is held by 203 institutional investors as of Q2 2026. Largest holders: BAKER BROS. ADVISORS LP ($1.2B), RTW INVESTMENTS, LP ($1.1B), Jupiter Topco LLC ($1B). Net institutional sentiment: Mixed.

203
Holders
(12 Elite)
$11.8B
Total Value
49% (205)
Consensus
100 buying - 105 selling
13F: Insider & Congress: Updated regularly
MDGL

Smart Money Verdict

View all
Loading verdict
Held by 203 funds
12 elite

Who's Trading

Source dates: Price Oct 14, 2026 · Insiders Sep 11, 2026 · Activists Jul 29, 2026 · Congress none

InsiderSJSibold William JohnSell $86KSep 11, 2026
InsiderSJSibold William JohnSell $837KSep 11, 2026
InsiderSJSibold William JohnSell $117KSep 11, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
2.1M(+0.1%)$1.2B5.8%+174.91%
62
Unchanged
2M$1.1B9.1%+72.98%
0
First report
1.9M$1B0.4%-14.33%
0
Increased
1.8M(+0.8%)$984.4M8.8%+183.24%
63
Decreased
1.3M(-3.8%)$719.5M27.9%+92.21%
0
Decreased
1.2M(-23.0%)$644.8M0.0%+37.82%
0
Increased
835,668(+1.0%)$448.7M0.0%-12.15%
31
Increased
825,714(+18.8%)$443.4M0.1%-7.20%
37
Decreased
781,731(-7.1%)$419.8M0.0%-12.12%
0
Decreased
527,057(-13.5%)$283M0.0%+139.74%
0
Increased
507,233(+11.8%)$272.4M0.0%-9.65%
34
Increased
401,708(+241.1%)$215.7M0.0%-2.33%
49
Decreased
374,880(-17.8%)$201.3M0.0%+135.82%
0
Decreased
356,201(-30.4%)$191.3M0.0%+59.53%
0
Decreased
324,123(-4.8%)$174M0.5%+38.98%
0
Decreased
301,435(-8.5%)$161.9M0.0%+19.36%
0
Decreased
246,280(-11.2%)$132.2M0.0%+40.26%
0
Decreased
244,274(-15.6%)$131.2M0.3%+38.07%
0
Increased
231,205(+135.5%)$124.1M0.0%-12.23%
49
Increased
210,205(+14.5%)$112.9M0.2%+78.13%
41

Showing 1-20 of 218

1 / 11
MDGLMDGLMADRIGAL PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used